A US pharma company has successfully tested a Food and Drug Administration-approved over the counter ointment as the first line of defence against the deadly coronavirus that has so far killed over eight lakh people globally.
Scientists associated with the project said the FDA-registered non-prescription over the counter (OTC) ointment has been proven to prevent, treat and kill viral infections including coronavirus.
As per the lab report states, no infectious virus was detected after 30 seconds of T3X treatment, the pharma company said in a statement.
We believe this will be a breakthrough that will reduce the likelihood of becoming infected with coronavirus through the nose, which is where most cases are contracted, said Dr Brian Huber, CEO and founder of Advanced Penetration Technology, which is based out of Indiana and Texas.
This is a big deal. It is the type of protection a lot of people have been hoping for and could be a first line of defence against the COVID virus. It is a powerful and effective layer of prevention, Huber said…